ISOM Meeting Information
PROGRAM-AT-A-GLANCE INTERNATIONAL SOCIETY OF OBSTETRIC MEDICINE 2-3 July, 2006 – Lisbon Congress Center
Sunday July 2, 2006 8.00-8.45 8.45-9.00 Registration/coffee-tea Welcome to ISOM Robyn North, President ISOM Chair: Cathy Nelson-Piercy, UK Karen Rosene-Montella Peter Garner memorial lecture: Obstetric Medicine: Where we are and where we need to go David d’Cruz Vasculitis in Pregnancy Chair: Gus Dekker, Australia Free communications: FC1 Structured Review: Obstetric outcomes in women with end-stage renal disease on chronic renal dialysis E. Thia, L-K. Tan, Singapore FC2 Pregnancy and HIV: Low vertical transmission despite high vaginal delivery rates K. Watkins, E. Howarth, C. Chapman, J. Houghton, M. Jethwa, J. Waugh, UK FC3 Management of Antenatal HIV infection in a DGH E. Draeger, J. Russell, UK FC4 Audit of Thyroid Disease in Pregnancy V. Kandasamy, J. Brennand, UK FC5 Hypothyroidism in Pregnancy N. Mahmood, G. Izzat, A. Mahmood, B. Salih, UAE
9.00-9.45
9.45-10.15
10.15-11.05
11.05-11.30 11.30-12.00
Coffee/tea Chair: Ray Powrie, USA Jolien Roos-Hesselink Pregnancy and coronary heart disease Jill Buyon Congenital Heart Block in Ro / La positive mothers: The Pathogenesis Bob Clandy Congenital Heart Block in Ro/La positive mothers:
12.00-12.30
12.30-13.00
Clinical Aspects 13.00-14.00 14.00-14.30 Lunch Chair: Mathew Sermer , USA Claire Mc Lintock Factor VII – What relevance for Obstetric Medicine? Free communications: FC6 To be or not to be a gestational diabetic - does it matter? D. Rajasingam, P. Carroll, C. Nelson-Piercy, A. Ash, S. Thomas, UK FC7 Ramadan Fasting in Pregnant Patients on Insulin N. Mahmood, S. Aziz, A. Mahmood, B.Salih, UAE FC8 Thrombophilia: A new potential risk factor for cervical insufficiency V-M. Ulander, U. Wartiovaara, L. Hiltunen , A. Rautanen, R. Kaaja, Finland 15.00-15.25 Chair: Janet Rowan (New Zealand) Ed Coetzee Is there a place for metformin or glybenclamide in the treatment of diabetes during pregnancy? R. Kaaja Insulin analogues in patients with diabetes during Pregnancy Chair: Ian Greer (UK) Free communications: FC9 Delivery by caesarean section does not delay blood coagulation returning to non-pregnant values H. Maybury, A. Gornall, S. Pavord, J. Waugh, UK
14.30-15.00
15.25-15.45
15.45-16.15
FC10 Peripartum thromboembolic risk by longitudinal thromboelastography (TEG): effects of mode of delivery E. Cordle, H. Maybury, R. Smith, S. Pavord, J. Waugh, UK
FC11 Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD): a randomised controlled trial M. Rodger, S. Kahn, A. Cranney, A. Hodson, M. Kovacs, A. Clement, A. Lazo-Langer, B. Hague, A. Karovitch, E. Keely, M. Walker, S. Robinson, M. Blostein, G. Smith, J. Kingdom, C. Demers, S. Solymoss, R. Khurana, E. Rey, P. Wells, Canada 16.15-17.00 17.00 ISOM business meeting with Coffee/tea ISSHP OPENING CEREMONY
Monday July 3, 2006 Joint ISSHP/ISOM session 13.30-14.30 Poster session ISSHP/ISOM. Posters no. P001-P068-A and Lunch 3 Parallel Sessions of Free communications ISSHP/ISOM Session 1 Diabetes and metabolic syndrome Chair: R. Kaaja, ROOM 3 14.30 O009 The Impact of Gestational Hypertension and Gestational Diabetes on Neonatal Outcome C. Stella, K. Forrester, J. O’Brien, N. Istwan, J. Barton, USA O010 A registry of Gestational Diabetes in Portugal: a work in progress of the Portuguese Diabetes Society Pregnancy Study Group of the Portuguese Diabetes Society T. Rocha, L. Ruas, J. Dores, M Carvalheiro, Portugal O011 Prevalence of metabolic syndrome among Sri Lankan women five years following pregnancy induced hypertension C. Wijeyaratne, D. Arandara, A. Arasalingam, P. Gunawardane, H. Seneviratne, Sri Lanka O012 Perinatal outcome in nulliparous women at very advanced maternal age (VAMA): the Toronto experience J. Keunen, C. Maxwell, M. Sermer, Canada O013 Cardiovascular risk profile of women with a history of pre-eclampsia A.Berends, C. de Groot, C. van Duijn, B.Oostra, E. Steegers, The Netherlands O014 Trends in incidence of GDM – Effect of screening methods and ethnicity M. Ezimokhai, A. Joseph, P. Bradley-Watson, UAE
14.30-16.00
14.40
14.50
15.00
15.10
15.20
15.30
O015 Elevated maternal Body Mass Index: Implications for obstetric management C. Maxwell, J. Keunen, M. Sermer, Canada O016 Outcomes of pregnancies affected by impaired glucose tolerance M. Kwik, S. Seeho, C. Smith, A. McElduff, J. Morris, Australia Session 2 Hypertension and cardiac disease Chair: W. Visser, ROOM 1
15.40
14.30
O017 Ang -(1-7) concentration and ACE2 mRNA levels are downregulated during the process of implantation and decidualization in Sprague - Dawley Rats L. Neves, K. Stovall, P. Gallagher, G. Valdes, C. Ferrario, D. Merrill, K. Brosnihan, USA O018 Pregnancy outcomes in women with congenital heart disease in a contemporary cohort M. Vasconcelos, R. Almeida, T. Pinho, C. Cruz, D. Ayres-Campos, F. Rocha-Gonçalves, Portugal O019 The chips pilot trial (Control of Hypertension In Pregnancy Study) L. Magee, P. von Dadelszen, S. Chan, A. Gafni, A. Gruslin, M. Helewa, S. Hewson, E. Kavuma, S. Lee, A. Logan, D. McKay, J. Moutquin, A. Ohlsson, E. Rey, S. Ross, J. Singer, A. Willan, M. Hannah, Canada O020 Parenteral intravenous optimal therapy trail – a RCT of hydralazine versus mini-bolus diazoxide for hypertensive crises in the obstetric setting A. Hennessy, C. Thornton, A. Makris, R. Ogle, D. Henderson Smart, A. Gillin, A. Child, Australia O021 Inherited thrombophilia polymorphisms and pregnancy outcome in asymptomatic nulliparous women: a prospective cohort study in an Australian antenatal population J. Said, J. Higgin, E. Moses, S. Walker, A. Borg, J. Campbell, P. Monagle, S. Brennecke, Australia O022 The blood pressure in pre-eclampsia (PE) - Grandfathers contribute too F. Broughton Pipkin for The GOPEC Consortium, UK O023 Primary hyperaldosteronism in pregnancy: a case series T. Podymow, M. Brucculeri, P. August, USA O024 Subcapsular liverhematoma in pregnancy: a Rotterdam review M. van den Berg, W. Visser, The Netherlands
14.40
14.50
15.00
15.10
15.20
15.30
15.40
Session 3 Maternal disease Chair: W. Steyn, ROOM 2 14.30 O025 Obstetric Cholestasis. The St George Experience C. Mackenzie, G. Davis, M. Brown, G. Mangos, Australia O026 Pregnancy after renal transplantation: a single centre experience L. Oliveira, J. Medina Pestana, K. Osaki, J. Sato, N. Sass, UK O027 Intrahepatic cholestasis of pregnancy in multiples: an analysis of risks and pregnancy outcomes A. Lausman, E. Al-Yaseen, D. Sam, R. Nitsch, W-S. Chan, Canada
14.40
14.50
15.00
O028 Pregnancy following renal transplant in the west of Scotland A. Nicoll, E. Macgregor, M. Gorrie, J. Brennand, UK O029 Outcomes of successive pregnancies in female kidney recipients reporting pre-eclampsia in their first post-transplant pregnancy J. Davison, L. Coscia, P. Silva, M. Moritz, V. Armenti, UK O030 A prospective study of pregnancies complicated by systemic lupus erythematosus and managed in a dedicated high risk clinic V. Jain, M. Toal, V. Chaddha, C. Chan, C. Laskin, R. Shupak, R. Windrim, M. Sermer, J. Kingdom, Canada O031 Outcome prediction in critically ill obstetric and gynaecology patients: a series of 260 cases F. Paruk, S. Bhagwanjee, D. Muckart, P. Becker, J. Moodley, South Africa O032 Pregnancy and renal transplant - impact of pregnancy on renal graft function A. Galvão, A. Areia, L. Freitas, M. São José, M. Campos, Portugal Coffee-Break PLENARY SESSION ON OBESITY AND METABOLIC SYNDROME AND SUBSEQUENT MATERNAL HEALTH Chair: E. Steegers B. Walters Pregnancy: a stress test for life D. Williams The metabolic syndrome as common road to pre-eclampsia and atherosclerosis? N. Sattar Diabetes after gestational diabetes: prevalence, prediction and prevention S. Kjos ISOM Dinner
15.10
15.20
15.30
15.40
16.00 16.30
16.30-17.00
17.00-17.30
17.30-18.00
20.00